| Pharmaceutical Information |
| Drug Name |
Dextroamphetamine |
| Drug ID |
BADD_D00636 |
| Description |
Dextroamphetamine is the dextrorotary enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label]. |
| Indications and Usage |
Used to treat attention deficit hyperactivity disorder (ADHD). |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
N06BA02 |
| DrugBank ID |
DB01576
|
| KEGG ID |
D03740
|
| MeSH ID |
D003913
|
| PubChem ID |
5826
|
| TTD Drug ID |
D0T3LF
|
| NDC Product Code |
27808-085 |
| Synonyms |
Dextroamphetamine | Dexamphetamine | Dexamfetamine | dextro-Amphetamine | dextro Amphetamine | d-Amphetamine | d Amphetamine | Dexedrine | DextroStat | Oxydess | Curban | Dextroamphetamine Sulfate | Sulfate, Dextroamphetamine | Dextro-Amphetamine Sulfate | Dextro Amphetamine Sulfate | d-Amphetamine Sulfate | d Amphetamine Sulfate |
|
| Chemical Information |
| Molecular Formula |
C9H13N |
| CAS Registry Number |
51-64-9 |
| SMILES |
CC(CC1=CC=CC=C1)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
